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2Summary
Polyglycylation is a posttranslational polymodification that generates glycine side 
chains on proteins. It was discovered more than ten years ago on tubulin, and is 
prominent in cilia and flagella. Yet the enzymes that catalyze tubulin polyglycylation 
have remained unknown. Here we describe the identification of a family of evolutionary 
conserved glycine ligases that modify tubulin. In mammals, two distinct enzyme types 
catalyze the initiation and elongation steps of polyglycylation, whereas the Drosophila
enzymes are bifunctional. Depletion of a polyglycylase in Drosophila using RNA 
interference results in adult flies with strongly decreased polyglycylation levels and 
male sterility associated with defects in sperm individualization and axonemal 
maintenance. A more severe RNAi depletion is lethal at early developmental stages, 
indicating that protein glycylation is essential. Together with the observation that 
multiple proteins are polyglycylated, our functional data point towards a general role of 
polyglycylation in protein functions. 
3Introduction
Polyglycylation is a posttranslational modification that generates side chains of 
glycine on the -carboxyl groups of specific glutamate residues of target proteins (Bré et 
al., 1998; Vinh et al., 1999). Similarly to polyglutamylation (Eddé et al., 1990), this 
posttranslational modification was discovered on tubulin, where it occurs within the 
carboxy-terminal tail domains (Redeker et al., 1994). While polyglutamylation was 
observed on many different types of microtubules (MTs), polyglycylation is particularly 
prominent in cilia and flagella and is mostly found in cells that possess these organelles 
(Bré et al., 1996; Levilliers et al., 1995).
Functional experiments on tubulin glycylation were difficult to perform since the 
modifying enzymes were unknown. Initial insights into the potential function of 
polyglycylation were obtained using modification-specific antibodies. For example, 
anti-glycylation antibodies affected axoneme beating in vitro, suggesting that tubulin 
polyglycylation could regulate ciliary dynein (Bré et al., 1996). In Tetrahymena, the 
elimination of the major glycylation sites on -tubulin was lethal or led to severe 
axonemal defects, including short axoneme size, absence of the central pair MTs, and 
incomplete outer doublet MTs (Redeker et al., 2005; Thazhath et al., 2002; Xia et al., 
2000). Thus, tubulin glycylation could be an important regulator of both the assembly 
and functions of axonemal MTs. The recent observations that non-tubulin proteins are 
also substrates of polyglycylation (Ikegami et al., 2008; Lalle et al., 2006; Xie et al., 
2007) indicate that glycylation is a posttranslational modification of general importance. 
Here we describe the discovery of a group of enzymes that catalyze tubulin 
glycylation and show that some of these enzymes have non-tubulin substrates. We 
4demonstrate that glycylases are members of the tubulin tyrosine ligase-like (TTLL) 
family, which already contains three types of known amino acid ligases, the tubulin 
tyrosine ligase (TTL; Ersfeld et al., 1993), polyglutamylases (Janke et al., 2005; van 
Dijk et al., 2007; Wloga et al., 2008) and an enzyme that ligates glycine to nucleosome 
assembly protein 1 (NAP1; Ikegami et al., 2008). We show that in mouse, TTLL3 and 
TTLL8 proteins are initiating glycylases with different substrate specificities, whereas 
TTLL10 is the elongating polyglycylase. Cooperation of these two types of enzymes 
generates polyglycine side chains in mammals, whereas in Drosophila, bifunctional 
enzymes catalyze both reactions. We also demonstrate that the previously reported 
absence of long glycine side chains on human sperm tubulin (Bré et al., 1996) is caused 
by two inactivating amino acid substitutions in human TTLL10. Finally, we show by 
RNA interference (RNAi) that depletion of one of the two glycylases in Drosophila
leads to strong reduction in polyglycylation, which causes defects in sperm maturation 
and results in male sterility. Moreover, expression of interfering RNA under a stronger 
promoter is lethal in early developmental stages. This suggests that polyglycylation is 
important for whole-organism development in Drosophila. The identification of new 
substrates of glycylation indicates that this modification could have a broad range of 
functions. 
Results
Identification of murine polyglycylases
Our study was initiated with the hypothesis that tubulin glycylases, like two other 
types of tubulin amino acid ligases, TTL (Ersfeld et al., 1993) and polyglutamylases 
(Janke et al., 2005; van Dijk et al., 2007), are members of the TTLL protein family. 
5Within the mammalian TTLL family, TTLL3, 8, 10 and 12 remained uncharacterized. 
According to phylogenetic studies, the TTLL12 gene is present in species that appear to 
lack glycylation (Janke et al., 2005; Schneider et al., 1997), and murine TTLL12 has no 
glycylation activity in vivo and in vitro (KR, unpublished observations). In contrast, the 
presence of orthologs of TTLL3, 8 and 10 in genomes of diverse species (Janke et al., 
2005) correlates with the known presence of tubulin glycylation, and a recent study 
showed that one of these three genes, TTLL10, encodes a glycylase for NAPs (Ikegami 
et al., 2008).
To test whether mouse TTLL3, 8 and 10 have a tubulin glycylase activity, we 
expressed the respective cDNAs (van Dijk et al., 2007) in HEK293 cells and tested the 
cell extracts in an in vitro MT glycylation assay. To distinguish between two possible 
types of activities, initiation (addition of the first glycine to a -carboxyl group of the 
target glutamate residue) and elongation of glycine side chains, we used substrates 
differing in the levels of tubulin glycylation: MTs polymerized from brain tubulin (that 
lack detectable glycylation) and strongly glycylated MTs of ciliary axonemes of 
Tetrahymena thermophila. Both, TTLL3 and 8 promoted incorporation of [3H]-glycine 
into brain MTs, but had very low activity on axonemal MTs. In contrast, TTLL10 was 
almost inactive on brain MTs, but promoted efficient [3H]-glycine incorporation into 
axonemal MTs (Fig. 1A). These observations suggest that TTLL3 and 8 are initiating 
glycylases, whereas TTLL10 is an elongating glycylase (polyglycylase) for tubulin. A 
similar functional specialization has been previously observed among polyglutamylases 
(van Dijk et al., 2007; Wloga et al., 2008). 
We also examined the selectivity of the enzymes for - and -tubulin. TTLL3 and 
8 modified both, - and -tubulin of brain MTs, with TTLL8 showing preference for -
6tubulin (Fig. 1A). For TTLL10, which modified only axonemal MTs, two-dimensional 
electrophoresis was used to separate axonemal - and -tubulin. Using anti-- or -
tubulin antibodies as well as TAP952 (an antibody that recognizes monoglycylated sites 
on tubulins; Bré et al., 1998) we found that both tubulin subunits of Tetrahymena
axonemes are monoglycylated, and thus are potential substrates for the elongation 
reaction. However, TTLL10 incorporated [3H]-glycine mainly into -tubulin (Fig. 1B).
Next, we expressed TTLL3, 8 and 10 in U2OS cells and labeled the cells with 
antibodies that are specific to either mono- or polyglycylation: TAP952 and polyG 
(polyG specifically recognizes polyglycine chains; Duan and Gorovsky, 2002), 
respectively (Fig. 1C). Non-transfected U2OS cells show no reactivity with either of 
these two antibodies (arrowheads). After expression of TTLL3 or 8, we detected 
specific labeling of MTs with TAP952, but not with polyG. Thus, TTLL3 and 8 mediate 
initiation of glycine side chains on MTs in vivo, but not side chain elongation. In 
contrast, cells expressing TTLL10 alone showed no labeling with TAP952, but had a 
diffuse labeling with polyG that did not correspond to MTs. This suggests that TTLL10 
adds polyglycine chains directly onto proteins that are not associated with MTs, while it 
cannot modify MTs without prior monoglycylation. 
Two-step glycylation mechanism in mammals
To test whether the two types of mammalian glycylases can function in a 
cooperative manner to create long side chains on MTs, we co-overexpressed either 
TTLL3 or 8 together with TTLL10 in U2OS cells. In both cases, we observed a strong 
labeling of MTs with the polyG antibody (Fig. 2A). These results indicate that MTs 
7have acquired polyglycine side chains, which was not the case when TTLL3, 8 or 
TTLL10 were expressed alone (Fig. 1C). 
On immunoblots, the monoglycylation-specific antibody TAP952 detected strong 
signals in the tubulin region upon expression of TTLL3 or 8 alone. Additional protein 
bands were labeled after TTLL8 expression, suggesting that TTLL8 can mediate 
glycylation of other non-tubulin proteins (Fig. 2B). TTLL3 increased glycylation of 
mostly -tubulin in U2OS cells, while it promoted modification of both - and -
tubulin in the in vitro assay (Fig. 2B, 1A). Thus, it appears that the substrate preferences
of the glycylating enzymes change depending on additional factors. Neither TTLL3 nor 
TTLL8 alone generated polyG-reactive epitopes, indicating that they are indeed 
restricted to reactions that generate monoglycine side chains (Fig. 2B). In contrast, no 
TAP952 labeling was detected in extracts of cells expressing TTLL10. However, a 
strong polyG signal was induced on two distinct protein bands, one of them the size of 
-tubulin (Fig. 2B). We demonstrate that the substrate in the tubulin region corresponds 
to NAPs. First, two-dimensional immunoblot analysis shows that the polyglycylated 
50 kDa protein band superimposes with NAPs, but not with tubulins (Fig. 2C), and 
second, ectopically expressed NAP1-EYFP and NAP2-EYFP were strongly 
polyglycylated by TTLL10 (Fig. S1). This is in agreement with the results of Ikegami et 
al. (2008) and indicates that in contrast to tubulins, NAPs can be polyglycylated directly 
by TTLL10.
After co-expression of TTLL3 or 8 with TTLL10, no TAP952 labeling was 
detected, whereas several protein bands were labeled with the polyG antibody. Virtually 
all protein bands labeled with TAP952 after expression of TTLL3 or 8 alone became 
labeled with polyG when TTLL10 was co-expressed (Fig. 2B), suggesting that 
8following monoglycylation by TTLL3 or 8, TTLL10 elongates glycine side chains of all 
major substrates of the initiating enzymes. The efficiency of this process is illustrated 
by the reduction of monoglycylated epitopes below detectable levels. This further 
indicates that the substrate specificity of polyglycylation in mammals is predetermined 
by the specificity of the initiating glycylases rather than by the elongating enzyme, 
except for proteins that are directly modified by TTLL10, such as the NAPs. 
Loss of elongating activity in humans
Human sperm axonemes, unlike sperm axonemes of several other mammalian 
species studied so far, have side chains limited to monoglycylation (Bré et al., 1996). 
We confirmed this by comparing the status of glycylation in protein extracts prepared 
from mouse, rhesus monkey and human sperm using the TAP952 and the polyG 
antibody (Fig. 3A). Several mouse and rhesus protein bands were strongly labeled with 
polyG, while only weak signals were detected with TAP952. In contrast, human sperm 
proteins were not labeled with polyG, but strongly with TAP952. No differences 
between the three species were found for the related tubulin modification, 
polyglutamylation (Fig. 3A, panel polyE). 
To determine the molecular basis for the lack of elongated polyglycine chains in 
human sperm, we investigated the only known elongating glycylase in mammals, 
TTLL10. First, we confirmed the presence of a full-length mRNA by cloning TTLL10 
from human testes cDNA. We then expressed human, mouse and rhesus TTLL10 in 
U2OS cells. The mouse and rhesus TTLL10 generated polyglycylation that could be 
specifically detected with polyG, whereas the human protein was inactive (Fig. 3B). 
Accordingly, when cell extracts from HEK293 cells overexpressing the respective 
9TTLL10 proteins were used for in vitro assays, only the mouse and rhesus, but not the 
human TTLL10 mediated incorporation of [3H]-glycine into axonemal MTs (Fig. 3C). 
Domain-swapping experiments localized the inactivating mutations to the central region 
of human TTLL10, which corresponds to the highly conserved core TTL domain 
(Fig. S3, S4A, B; van Dijk et al., 2007). Within this domain, human and rhesus TTLL10 
differ by 11 amino acids, out of which 4 are not evolutionarily conserved. Thus, we 
analyzed the remaining 7 amino acid changes by introducing them separately into the 
rhesus TTLL10. Two of these mutations led to a complete loss of polyglycylase activity 
(Fig. S3, S4C), suggesting that the corresponding amino acids are essential for activity. 
When these two mutations in human TTLL10 were both reverted to the conserved 
amino acids found in rhesus and mouse, the enzyme recovered polyglycylase activity 
(Fig. 3D, E). This was not the case if only one mutation was reverted. As neither of the 
two mutations has been found in the genomes of the great apes (not shown), it appears 
that humans are unique in having lost the polyglycylation activity of TTLL10. One of 
the two inactivating mutations (mut3) is polymorphic in the human population, leading 
to a high incidence (55.0% heterozygote and 16.7% homozygote) of TTLL10 alleles 
without mut3 in the sub-Saharan African population, whereas 91.7% of the European 
population are homozygote for the presence of mut3
(http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1320571). No polymorphism was 
found for mut5. To investigate if the mut3 polymorphism could affect the enzymatic 
activity of TTLL10, we compared polyglycylation of sperm proteins from two 
homozygote individuals either with or without mut3, but both bearing mut5 (Fig. S5A). 
The complete absence of polyglycylation on sperm proteins from both individuals 
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(Fig. S5B) confirmed that the presence of one of the two inactivating mutations is 
sufficient for the complete loss of enzymatic activity of human TTLL10 (Fig. S4C). 
In conclusion, we show that the human elongating polyglycylase TTLL10 is 
functionally inactive due to two mutations, resulting in the absence of polyglycylation 
in sperm. Considering that all known amino acid ligases that modify tubulin are 
members of the TTLL family, and that all TTLLs are expressed in testes (Ersfeld et al., 
1993; van Dijk et al., 2007), it is likely that TTLL10 is the only polyglycylating enzyme 
in mammals. Thus, humans could be a unique mammalian species that lacks protein 
polyglycylation. 
Cancer-associated mutations inactivate the TTLL3 enzyme
In a recently published screen for putative cancer-associated genes, TTLL3
obtained a relatively high score as a potential cancer gene (Sjöblom et al., 2006). It was 
striking that the two mutations identified in the screen were localized in the vicinity of 
the ATP-binding residue E662, which is essential for enzymatic activity in all TTLLs 
(Fig. 4A; van Dijk et al., 2007). To test the potential impact of these mutations, we 
introduced them separately into mouse TTLL3, which is identical to human TTLL3 in 
this region (Fig. 4A), and tested the enzymatic activity of the mutated enzymes. Each 
cancer-related mutation led to a complete loss of glycylase activity of TTLL3 in vivo
and in vitro (Fig. 4B-D), suggesting that loss of monoglycylating activity could be 
related to cancer. 
A divergent polyglycylation mechanism in Drosophila
In mammals, TTLL10 is the only enzyme able to elongate glycine side chains. 
However, in Drosophila, an organism with polyglycylated MTs (Bré et al., 1996), only 
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two orthologs of the TTLL3/8 group are present, whereas no TTLL10 gene has been 
found (Janke et al., 2005). To establish the enzymatic mechanism that leads to the 
elongation of glycine side chains in the absence of TTLL10, we investigated the activity 
of the Drosophila melanogaster (dm) enzymes dmTTLL3A (CG11323) and 
dmTTLL3B (CG11201) in U2OS cells. Both enzymes induced monoglycylation on 
MTs (Fig. 5A, panel TAP952). Some cells expressing dmTTLL3B showed a restricted 
localization of this enzyme to the nucleus, and accordingly, only the nucleus was 
labeled with TAP952 in those cells (Fig. 5A, #). However, in contrast to the mammalian 
orthologs (Fig. 1C), dmTTLL3A also generated polyglycylated MTs as detected with 
polyG, while dmTTLL3B polyglycylated nuclear proteins, but not MTs (Fig. 5A, panel 
polyG). Immunoblots revealed that dmTTLL3A initiates and elongates glycine side
chains on - and -tubulin, whereas dmTTLL3B initiates glycylation on number of 
proteins including -tubulin, but functions as an elongating polyglycylase only for non-
tubulin substrates (Fig. 5B). These polyglycylated substrates of yet unknown identity 
are likely to be responsible for the observed nuclear staining (Fig. 5A). Thus, 
Drosophila has a polyglycylation mechanism that utilizes bifunctional 
initiating/elongating polyglycylases. 
dmTTLL3B is essential in Drosophila
Polyglycylation is particularly abundant in testes where it is associated with the 
axonemes of the sperm flagella (Bré et al., 1996; Bressac et al., 1995). In Drosophila, 
one of the polyglycylase genes, dmTTLL3B, is highly expressed in testes (Fig. S6), 
suggesting that dmTTLL3B is the major polyglycylase in this organ. Thus, we 
attempted to deplete dmTTLL3B by RNA interference (RNAi), using a transgenic fly 
carrying inverted repeats that correspond to dmTTLL3B under the control of UAS
12
sequences inducible by Gal4 (UAS-IR-dmTTLL3B transgene). Strikingly, 50% of the 
embryos carrying UAS-IR-dmTTLL3B and the ubiquitous da-Gal4 driver (dmTTLL3Bda-
RNAi) did not survive to adulthood (Fig. 6A). 
RT-PCR analysis of adult dmTTLL3Bda-RNAi flies demonstrated that dmTTLL3B
inverted repeats were expressed and dmTTLL3B mRNA levels were strongly decreased. 
In contrast, mRNA levels of the closest homolog of this gene, dmTTLL3A, were 
unchanged (Fig. 6B), demonstrating the specificity of the dmTTLL3B RNAi. 
Immunoblots of whole-protein extracts showed a strong reduction of polyG-labeling on 
a range of protein bands in the dmTTLL3Bda-RNAi flies (Fig. 6C), whereas 
polyglutamylation levels were slightly increased in males but not in females (Fig. 6C, 
panel GT335). These data provide strong evidence that the majority of the protein 
polyglycylation in Drosophila is catalyzed by dmTTLL3B. Almost all adult male
dmTTLL3Bda-RNAi flies were sterile, as only 2.4% were able to generate offspring 
(Fig. 6D), although with 20 times less progeny as compared to wild type. This suggests 
that polyglycylation is important for spermatogenesis. 
The process of spermatogenesis in Drosophila can be divided into three major 
steps: (i) the generation of 64 haploid, interconnected spermatocytes from a stem cell, 
(ii) the formation of the axonemes and the condensation of the sperm nuclei in the still 
interconnected spermatids and (iii) the individualization that resolves the syncytial 
sperm bundle into 64 separate sperm cells. This last step is achieved by a group of 
synchronously moving individualization complexes that remove excess cytoplasm and 
place the membranes around each cell. To determine which of the three steps were 
affected in dmTTLL3Bda-RNAi flies, we analyzed the testes by immunofluorescence and 
transmission electron microscopy (TEM). In immunofluorescence (Fig. 6E) of wild type 
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testes, the polyG antibody stained prominent bundles of fibers that correspond to the 
sperm tails. The actin staining visualized groups of regularly arranged individualization 
complexes, which were always associated with the polyG-reactive MT bundles, 
confirming that sperm polyglycylation appears at the onset of individualization (Bré et 
al., 1996; Bressac et al., 1995). In contrast, in dmTTLL3Bda-RNAi testes, polyG staining 
was strongly reduced and actin cones were scattered along the tails, indicating a sperm 
individualization defect (Fabrizio et al., 1998). Moreover, we observe that the tips of the 
testes were often enlarged in dmTTLL3Bda-RNAi male flies (Fig. 6E). 
To better understand the observed defects we compared cross-sections of sperm 
cysts at different stages of maturity using TEM. In the preindividualization stage, sperm 
cysts of both control and dmTTLL3Bda-RNAi flies appeared similar, as they contained the 
expected 64 sperm cells with an axoneme as well as a minor and a major mitochondrial 
derivate (Fig. 6F). Upon maturation, sperm cysts become more compact due to strongly 
reduced cytoplasmic ground substance. At this late stage, control cysts were highly 
organized as each axoneme was positioned in the close proximity of a major 
mitochondrial derivate (Fig. 6G, panel control). In contrast, most of the mature cysts 
from dmTTLL3Bda-RNAi flies were lacking the axoneme structures, whereas the 
mitochondrial derivates were still present (Fig. 6G, panels dmTTLL3Bda-RNAi). In some 
cases, disorganized axonemes composed of singlet MTs were found. We also observed 
rare cases of disorganized cysts that still contained axonemes, but had reduced or absent 
mitochondria. Together our findings indicate that polyglycylation plays a role in 
individualization and is essential for the maintenance of the axoneme structure at later 
stages. However, it is not required for the early steps of Drosophila spermatogenesis, 
including the assembly of the axonemes. 
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Finally, we hypothesized that the initially observed partial lethality of the 
dmTTLL3Bda-RNAi flies indicates an essential function of dmTTLL3B in Drosophila, and 
that the flies that reached adulthood survived due to the incomplete suppression of 
dmTTLL3B under the da-Gal4 driver. To test this hypothesis, we increased the 
efficiency of the RNAi by introducing the UAS-Dcr-2 transgene (Dietzl et al., 2007)
into the dmTTLL3Bda-RNAi flies. Strikingly, we observed 100% lethality at the larval 
stage. This phenotype is not due to side effects of the UAS-Dcr-2 transgene (Dietzl et 
al., 2007), since the expression of UAS-IR-dmTTLL3B under the control of the very 
strong and ubiquitous Act5C-Gal4 driver also led to 100% lethality (not shown). Thus, 
in addition to an important role in spermatogenesis, dmTTLL3B-mediated 
polyglycylation could be essential for Drosophila development.
Identification of potential new substrates of glycylation
The observation that mouse TTLL8 as well as Drosophila TTLL3B glycylate a 
range of non-tubulin proteins (Fig. 2B, 5B, 6C) raised the possibility that glycylation is 
a posttranslational modification with a broad range of substrates. Following the 
observation that the two most prominent substrates of polyglutamylation, tubulins 
(Eddé et al., 1990) and NAPs (Regnard et al., 2000), are also modified by 
polyglycylation (Redeker et al., 1994; Ikegami et al., 2008), we hypothesized that 
additional substrates of glycylation are among the previously identified substrates of 
polyglutamylation (van Dijk et al., 2008). We expressed 12 potential substrates of 
polyglutamylation together with either TTLL8 or an enzymatically inactive (dead) 
version of TTLL8 in HEK293 cells. Five proteins (ANP32A, ANP32B, SET, RanGAP 
and nucleolin) were found to be glycylated in the presence of active, but not inactive 
TTLL8 (Fig. 7). Seven other proteins tested (NF45, B23, GRP78, NASP, RNP-K, NCT, 
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EB1, data not shown) were not modified. To uncover additional substrates by a more 
direct approach, we separated proteins from fly testes using two-dimensional 
electrophoresis and analyzed polyG reactive proteins by mass spectrometry. We 
selected six of the identified proteins (Table S1; see supplementary information for 
more details) and co-overexpressed them with active or inactive TTLL8 in HEK293 
cells. Among these proteins, troponin T was found to be specifically glycylated by 
ectopic TTLL8 (Fig. 7). The identification of a range of potential substrates of 
glycylation suggests that this modification could regulate the function of many proteins. 
Thus, the lack of glycylation of several proteins, and not only tubulin, could have 
contributed to the defects observed in the dmTTLL3B depleted flies. 
Discussion
Polyglycylation was first described as a polymodification that generates glycine 
side chains of variable length on - and -tubulins (Redeker et al., 1994). Similarly to 
polyglutamylation, it targets the C-terminal tails of tubulins, which are the major 
interaction sites for MT-associated proteins and molecular motors (Nogales, 2000). 
Thus, polyglycylation could be an important regulator of MT functions. 
We have identified a group of enzymes that mediate the generation of glycine side 
chains on proteins. The glycylating enzymes are members of the TTLL family, which 
also contains other enzymes that catalyze amino acid ligations: tubulin tyrosine ligase 
(Ersfeld et al., 1993) and diverse polyglutamylases (Janke et al., 2005; van Dijk et al., 
2007; Wloga et al., 2008). Initiation and elongation of the glycine side chains are 
catalyzed by separate glycylases in mammals. Two initiating enzymes, TTLL3 and 
TTLL8, both generate monoglycylation on tubulin, whereas only TTLL8 modifies 
additional proteins. In agreement with our results, TTLL3 proteins in the ciliate 
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Tetrahymena and in zebrafish are also initiating tubulin glycylases (Wloga et al., 2009). 
The subsequent elongation of glycine side chains in mammals is catalyzed by the 
elongating polyglycylase TTLL10. 
The discovery of a strict two-step mechanism for MT polyglycylation in 
vertebrates raised two questions related to previous descriptions of polyglycylation 
patterns in different organisms. First, elongated glycine side chains are completely 
absent in human sperm tubulin (Bré et al., 1996). We show that this phenotype is 
directly related to human TTLL10, which lacks enzymatic activity due to two point 
mutations in the conserved core TTL domain. It is striking that these mutations appear 
to be unique to human TTLL10, which suggests that the loss of polyglycylation was an 
event important for human evolution. Furthermore, the existence of a species devoid of 
polyglycylation suggests that the “poly” character of glycylation is not essential for 
protein functions, and that the functions of glycylation could be efficiently fulfilled by 
monoglycylation, which is present in all cilia in mammals (Dossou et al., 2007). 
Another surprising observation was that Drosophila, an organism with reported 
polyglycine side chains on tubulin (Bré et al., 1996), has no homologs of TTLL10. We 
show that in Drosophila, glycylases from the TTLL3/8 group act as bifunctional 
enzymes that are able to catalyze both, initiation and elongation of glycine side chains, 
explaining why polyglycine side chains are present despite the absence of a TTLL10 
ortholog. The two distinct glycylation mechanisms in mammals and Drosophila
correlate with the previously described order of appearance of polyglycylation during 
sperm maturation. In mouse, polyglycine side chain elongation is delayed, appearing 
only after initial monoglycylation (Kann et al., 1998), whereas in Drosophila, mono-
and polyglycylation occur simultaneously (Bré et al., 1996). 
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In Drosophila the depletion of dmTTLL3B induced a significant decrease in 
glycylation, accompanied by decreased viability and an almost complete sterility of the 
surviving males. Detailed analysis of the dmTTLL3Bda-RNAi flies revealed that the lack of 
dmTTLL3B affects late stages of spermatogenesis. This coincides with the timing of 
appearance of glycylation in Drosophila sperm development (Bressac et al., 1995). We 
observed that although axonemes were assembled, they become unstable and 
disassemble in final stages of spermatogenesis. The disassembly of the axonemes is 
likely to proceed through a stage in which MT doublets are reduced to singlets, 
followed by the complete disappearance of all MT structures. Thus, one of the roles of 
glycylation in spermatogenesis appears to be the maintenance of the axonemal structure, 
whereas the modification is not required for the assembly.
Due to their sensory role in cells, cilia are centers of signal transduction pathways 
involved in embryonic development and tissue homeostasis in adults. Therefore, defects 
in cilia can be related to cancer (Mans et al., 2008; Michaud and Yoder, 2006). Our 
finding that two cancer-related mutations in TTLL3 (identified by Sjöblom et al. 2006) 
both completely inactivate this enzyme, suggests that the lack of TTLL3 activity could 
affect cilia, which in turn could contribute to cancer progression. 
The complexity of signals generated by polyglutamylation and polyglycylation on 
MTs could allow for different modes of regulation. Besides the possibility that both 
polymodifications generate signals for different target proteins, glycylation could also 
function as a counter-regulator of polyglutamylation, since both modifications compete 
for similar modification sites on tubulin (Redeker et al., 2005). In agreement with this 
hypothesis, we show that tubulin polyglutamylation increases upon depletion of 
polyglycylation. Such a function could be sufficiently fulfilled by monoglycylation, 
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which would help explaining the apparent lack of phenotypes related to the loss of 
elongated glycine side chain in humans. 
Most of the past work on glycylation has been focussed on the role of this 
modification in MT functions; however, several recent studies have shown that other 
proteins are substrates of glycylation (Ikegami et al., 2008; Lalle et al., 2006; Xie et al., 
2007). Together with our results, this opens the possibility that glycylation targets a 
broad range of substrates.
To conclude, we have identified a new group of tubulin modifying enzymes and 
two evolutionarily divergent mechanisms for glycyl side chain initiation and elongation. 
Functional studies in Drosophila show that glycylation is important for sperm 
maturation, and that it might also be essential in early developmental stages in flies. 
Finally, the discovery that several important proteins could undergo glycylation raises 
the possibility that this modification acts as a general regulator of cellular functions.
Experimental procedures 
Cloning and mutagenesis
Mouse TTLL3, 8 and 10 have been identified and cloned before (van Dijk et al., 2007). 
The rhesus monkey (Macaca mulatta) TTLL10 cDNA sequence was reconstructed from 
fragments found by NCBI Blast (http://www.ncbi.nlm.nih.gov/BLAST/) using known 
TTLL10 sequences as templates. The predicted sequence was amplified from testis 
cDNA (BioChain Institute Inc. Hayward, CA, USA), cloned and the DNA was 
sequenced. PCR-related mutations were excluded by sequencing of multiple clones 
(complete coding sequence: Fig. S2A). For human TTLL10, a splice variant (Fig. S2C) 
of the sequence AK124125 has been amplified from testis cDNA (BioChain Institute 
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Inc.) and verified by DNA sequencing. Drosophila dmTTLL3A (CG11323) and 
dmTTLL3B (CG11201) were cloned from cDNA from adult flies. 
Point mutations were introduced by a PCR-based quick-change method. The 
presence of the mutation was verified by DNA-sequencing. 
Drosophila genetics
Drosophila was grown on standard medium at 25°C. The w1118, UAS-IR-TTLL3B
transgenic line was obtained from the Vienna Drosophila RNAi Center (www.vdrc.at). 
The transgene, localized on the X chromosome, expresses an inverted repeat from the 
dmTTLL3B gene (CG11201) under the control of UAS sequences. UAS-IR-TTLL3B flies 
were crossed with strains carrying the da-Gal4 or the Act5C-Gal4 driver. For 
amplification of the RNAi-effect, the da-Gal4 transgene was associated with the UAS-
Dcr-2 transgene (Dietzl et al., 2007), and the resulting strain was crossed with UAS-IR-
TTLL3B flies. Total RNA was extracted from adult flies with TRIZOL reagent (Sigma), 
and reverse transcription was performed using the First-Strand cDNA synthesis kit (GE 
Healthcare) with 5 µg of RNA and random hexamers as primers. 1/60 of this cDNA was 
used for PCR amplification. Primer pairs used for the detection of different gene 
transcripts can be provided on request. Number of PCR-cycles used for RT-PCR: 
RNAi, dmTTLL3B: 30, dmTTLL3A: 35, rp49: 25. Male fertility was tested in 
individual crosses with w1118 females, and the presence of progeny was scored after 
2 weeks. 
Isolation of axonemes from Tetrahymena cilia
CU427 Tetrahymena cells were grown in SPP medium (1% proteose peptone, 
0.2% glucose, 0.1% yeast extract, 0.003% EDTA ferric sodium salt) at 30°C to mid log 
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phase (4-5x105 cells/ml). Cilia were collected as described (Brown et al., 1999) and 
stored at -80°C. For the preparation of axonemes, cilia were demembranated using 0.2% 
NP40 in 1x ERB buffer (50 mM Tris/HCl, pH 8.0, 10% glycerol, 5 mM MgCl2, 1 mM 
EGTA). To remove the endogenous glycylase activity, axonemes were further treated 
with 1 M NaCl in 1x ERB for 30 min, followed by an incubation at 60°C for 20 min. 
Axonemes were spun down (12,000 g, 30 min, 4°C), and the supernatant was discarded. 
The pellet was then washed in 1x ERB and resuspended in 1x ERB at a final 
concentration of 5 mg/ml.
Tubulin polyglycylation assay
The enzymatic activity of glycylase was determined based on incorporation of 
[3H]-glycine into MTs. The assay was performed in 50 µl of 1x ERB supplemented with 
2 mM ATP and 250 pmol (5 µl) [3H]-glycine (20.0 Ci/mmol, GE Healthcare). 
Enzymatic activity was measured using cells extracts prepared in 1x ERB containing 
0.2% NP-40. 20 µg of axonemal or taxotere-stabilized MTs (prepared from adult mouse 
brains as described; Regnard et al., 1999) were resuspended in the reaction mixture and 
immediately transferred to 30°C, followed by 4 h of incubation. The samples were then 
subjected to SDS-PAGE (10% gels) and electrotransferred onto nitrocellulose 
membrane. The tubulin bands were visualized by staining with Ponceau S, cut out and 
placed in 5 ml of scintillation liquid (Ultima Gold, Perkin Elmer) for quantification. 
Alternatively, SDS-PAGE gels were stained with Coomassie Blue, incubated in 
Amersham AmplifyTM (GE healthcare), and [3H]-glycine incorporation was visualized 
by autoradiography. 
Affinity-purification of EYFP-tagged proteins
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EYFP-tagged potential substrates were co-expressed with TTLL8 in HEK293 
cells. After lyses of the cells in PBS, 0.2% NP40, the supernatant (100,000 g, 30 min, 
4°C) was incubated with GFP-TRAP® agarose beads (ChromoTek, Martinsried, 
Germany) for 4 h at 4°C. Beads were washed twice in PBS, 0.2% NP40 and boiled in 
Laemmli sample buffer for 5 min. The samples were spun at 20,000 g for 5 min and 
supernatants were analyzed by SDS-PAGE and immunoblot.
Protein electrophoresis and immunoblot
One-dimensional SDS-PAGE was performed using standard protocols, or a 
special protocol for the separation of mammalian - and -tubulin (Eddé et al., 1987). 
Two-dimensional electrophoresis consisted of an isolelectric focusing step (IPGphor 
Isoelectric Focusing System; GE Healthcare) and a SDS-PAGE. For the resolution of 
the tubulin in Fig. 1B, 40 µg of tubulin were loaded on 18 cm pH 4.5-5.5 Immobiline 
strips (GE Healthcare). Cell extracts shown in Fig. 2C were prepared directly in the 
loading buffer (7 M urea, 2 M thiourea, 4% (w/v) CHAPS, 2% (v/v) IPG buffer (GE 
Healthcare), 40 mM DTT) and resolved in 8.5 cm pH 3.0-5.6 Immobiline strips (GE 
Healthcare). 
Membranes were incubated with the following antibodies: polyG (1:6,000), polyE 
(1:1,000; both courtesy of M. Gorovsky), TAP952 (Bré et al., 1998; ascitic fluid, 
1:2,000), 12G10 (Thazhath et al., 2002; 1:250), E7 (Chu and Klymkowsky, 1989; 1:20), 
12CA5 (1:10), anti-GFP (1:5,000; Torrey Pines Biolabs), anti-NAP 4A8 (Fujii-Nakata 
et al., 1992; Ishimi et al., 1985; 1:20). Antibodies against TTLL8 were raised in rabbits 
with bacterially expressed protein, and then purified on recombinant TTLL8 and used at 
1:500 dilution.
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Protein bands were visualized with HRP-labeled donkey anti-rabbit or anti-mouse 
IgG 1:10,000 (GE healthcare) followed by detection with ECL immunoblot detection 
kit (GE Healthcare). 
Immunofluorescence and microscopy
U2OS cells were cultured on glass coverslips under standard conditions and fixed 
using a protocol for preservation of cytoskeletal structures (Bell and Safiejko-Mroczka, 
1995). Fixed cells were incubated with TAP952 (hybridoma supernatant 1:200), polyG 
(1:3,000), anti-TTLL8 (1:1,000) or anti-GST (1:1,000) antibody for 1 h, followed by 
30 min with anti-mouse or anti-rabbit Alexa 555 or Alexa 488 antibody (1:1,000; 
Molecular Probes). DNA was visualized by DAPI staining (0.02 µg/ml). Coverslips 
were mounted with MOWIOL. Drosophila testes were fixed for 30 min with 3,7% 
paraformaldehyde in PBS, permeabilized in PBS containing 0.5% Triton X100, and 
incubated with polyG (1:9,000) for 1 h, followed by 30 min anti-rabbit Alexa 647. 
Actin was visualized with TRITC-conjugated phalloidin (1:10,000; Sigma). We used 
DMRA microscopes (Leica, Germany) and Metamorph (Universal Imaging Corp., 
USA) software.
For ultrastructural analysis, testes were isolated from 3-4 days old male flies and 
fixed in 3.5% glutaraldehyde in 100 mM phosphate buffer, pH 7.4 overnight at 4°C. 
The samples were rinsed in phosphate buffer and post-fixed in 1% osmic and 0.8% 
potassium ferrocyanide for 2 h in the dark at RT. After rinsing in phosphate buffer, 
samples were dehydrated in a series of ethanol solutions (30-100%) and embedded in 
EmBed 812 DER 736. 85 nm sections were cut on a Leica-Reichert Ultracut E 
microtome and counterstained with uranyl acetate and lead citrate. Images were aquired 
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with a Hitachi 7100 transmission electron microscope at the Centre de Ressources en 
Imagerie Cellulaire de Montpellier (France).
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Figure Legends: 
Figure 1 Enzymatic characterization of murine glycylases. 
(A) In vitro glycylation activity of TTLL3, 8 and 10 using MTs from brain that lack 
detectable glycylation and highly glycylated Tetrahymena axonemal MTs as substrates. 
The incorporation of [3H]-glycine was separately determined for - and -tubulin for 
brain, but not for axonemal MTs due to co-migration of both tubulin subunits. (B) Two-
dimensional analysis of - and -tubulin from Tetrahymena ciliary axonemes (12G10: 
anti -tubulin; E7: anti -tubulin). While both tubulin subunits are monoglycylated 
(TAP952 panel), the TTLL10-enriched fraction incorporates [3H]-glycine mainly into 
-tubulin in vitro (autoradiography panel). (C) Immunofluorescence analysis of U2OS 
cells overexpressing TTLL3-EYFP, TTLL8 or TTLL10-EYFP. TAP952 labels the MT 
cytoskeleton of cells expressing TTLL3 or 8, but not TTLL10. PolyG antibody detects a 
diffuse staining after TTLL10 overexpression. Non-transfected cells, visualized by 
DAPI-staining of the nuclei, are neither labeled with TAP952 nor with polyG 
(arrowheads). *TTLL8 was expressed as an untagged protein and detected with anti-
TTLL8 antibody. Scale bar is 20 µm. 
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Figure 2 The cooperative mechanism of murine polyglycylases. 
(A) Immunofluorescence of U2OS cells co-expressing TTLL10-ECFP together with 
TTLL3-EYFP or TTLL8-EYFP. Note that polyG antibody labels the cytoskeleton. 
Scale bar is 20 µm. (B) Immunoblot analysis of extracts from U2OS cells expressing 
TTLL3-EYFP, TTLL8 and TTLL10-6HA alone as well as TTLL3-EYFP or TTLL8 in 
combination with TTLL10-6HA. TAP952 recognizes protein bands exclusively in cell 
extracts after expression of TTLL3 or 8. Different proteins are detected with polyG 
antibody after overexpression of TTLL10 alone or in combination with TTLL3 or 8. (C)
Two-dimensional electrophoresis and immunoblot of extracts from control U2OS cells 
(-) or cells expressing TTLL10-6HA (+). The positions of - and -tubulin as well as 
NAPs are determined with specific antibodies. (# polyglycylated NAPs; * non-specific 
polyG signal)
Figure 3 Evolutionary loss of polyglycylation in humans.
(A) Immunoblot analysis of mouse, rhesus and human sperm proteins. The polyG 
antibody detects specific protein bands in mouse and rhesus, but not in human sperm. In 
contrast, TAP952 detects tubulin bands at a low level in mouse and rhesus, but strongly 
in human. The polyE antibody labels tubulin of all three species equally strong. (B)
Immunoblot analysis of extracts from U2OS cells expressing mouse, rhesus or human 
TTLL10. (C) In vitro enzymatic assay of mouse, rhesus and human TTLL10 expressed 
in HEK293 cells with axonemal MTs as a substrate. (D) Immunoblot of U2OS cells 
expressing wild type rhesus and human TTLL10, as well as human TTLL10 containing 
sequence reversions to amino acids present in rhesus and mouse TTLL10 (see Fig. S3): 
S 448 N (rev3; reversion of mut3; see Fig. S4C), K 467 T (rev5; reversion of mut5; see 
Fig. S4C), or both of them (rev3+5). Wild type rhesus TTLL10 and human TTLL10 
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carrying both rev3 and rev5 generated a strong polyG signal on NAPs, indicative of 
polyglycylase activity. (E) Schematic representation of the human TTLL10 protein 
indicating the localization of the two amino acid reversions that allowed for re-
activation of polyglycylase activity. The localization of the conserved core TTL domain 
(yellow) and the essential ATP-binding residue E511 are indicated (red; Fig. S3; van 
Dijk et al., 2007). 
Figure 4 Loss of enzymatic activity of TTLL3 in colon cancer.
(A) Sequence alignment of different TTLL proteins from different organisms maps 
the position of two cancer-related mutations in TTLL3 (G647S: green, M669I: pink; 
Sjöblom et al., 2006) to two highly conserved positions in the vicinity of the major ATP 
binding site (E662, yellow). Amino acids in red letters: homology, in blue: similarity. 
(B) TAP952 labeling of U2OS cells expressing wild type TTLL3-EYFP and the 
mutated proteins including the E622G ATPase dead version. Scale bar is 20 µm. (C) 
Immunoblot of extracts from U2OS cells expressing wild type and mutated TTLL3s. 
(D) In vitro glycylation assay of extracts from HEK293 cells expressing either the wild 
type or mutated forms of TTLL3 using brain MTs as substrate. 
Figure 5 The enzymatic mechanism of polyglycylation in Drosophila.
(A) Immunofluorescence analysis of U2OS cells expressing Drosophila 
melanogaster (dm) TTLL3A-EYFP and TTLL3B-EYFP proteins. TAP952 labels 
cytoskeletal structures in cells expressing either of these proteins; however, some cells 
with a dominant nuclear localization of dmTTLL3B (#) show only diffuse nuclear 
labeling with this antibody. PolyG decorates the cytoskeleton in cells expressing 
dmTTLL3A, but only the nucleus in the cells that express dmTTLL3B. Non-transfected 
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cells are visualized by DAPI-staining of the nuclei. Scale bar is 20 µm. (B) Immunoblot 
analysis of extracts from U2OS cells expressing dmTTLL3A and dmTTLL3B. Both 
enzymes generate specific labeling of protein bands with the TAP952 and polyG 
antibodies. (* non-specific polyG signal)
Figure 6 Effects of dmTTLL3B depletion in Drosophila.
(A) Comparison of the survival of female and male flies carrying UAS-IR-
dmTTLL3B transgene in the presence or absence of the driver. The percentage of viable 
adult flies as compared to the number of embryos is shown. (B) RT-PCR analysis of 
dmTTLL3B-RNAi, dmTTLL3B, dmTTLL3A and rp49 expression in control (da-Gal4/+) 
and dmTTLL3Bda-RNAi flies. (C) Immunoblots of whole-fly extracts, probed for 
polyglycylation (polyG), polyglutamylation (GT335) and -tubulin (12G10). In control 
(da-Gal4/+) flies, multiple proteins are labeled with polyG antibody in male and female 
flies. This labeling is strongly reduced in dmTTLL3Bda-RNAi flies. In contrast, 
polyglutamylation is only detected in male individuals, and increases upon depletion of 
polyglycylation. (D) Sterility of male flies carrying UAS-IR-dmTTLL3B transgene in the 
presence or absence of the driver. (E) Immunofluorescence of testes from control (da-
Gal4/+) and dmTTLL3Bda-RNAi flies. Actin is stained with TRITC-conjugated phalloidin 
(red), and polyglycylated proteins are revealed with polyG antibody (green). Nuclei are 
stained with DAPI (blue). In dmTTLL3Bda-RNAi flies, polyglycylation levels are 
decreased and actin cones are scattered. The tip of the testes (arrowhead) is enlarged. 
Insets show the distribution of actin cones (zoom 2.5x). Scale bar is 100 µm. (F and G)
Transmission electron micrographs of sections of cysts from control (da-Gal4/+) and 
dmTTLL3Bda-RNAi flies. Red arrowheads show axonemes, blue mitochondria. Scale bar is 
500 nm. (F) Immature cysts of dmTTLL3Bda-RNAi flies show no phenotypic abnormalities 
32
as compared to control. (G) Phenotype of mature cysts in control and dmTTLL3Bda-RNAi
flies. Abnormalities found in dmTTLL3Bda-RNAi flies include reduced number of 
mitochondria, disorganized axoneme structures (singlet microtubules; inset with 2.5x 
zoom) and complete absence of axonemes. 
Figure 7 New substrates of glycylation.
EYFP-tagged mouse or Drosophila proteins were co-expressed with active (A) or 
inactive (“dead”; D) mouse TTLL8 in HEK293 cells. After EYFP affinity purification 
proteins were detected with anti-GFP antibody, and the level of glycylation was 
determined with TAP952. The total extract was probed for TTLL8 expression with anti-
TTLL8 antibody.
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Supplementary figures:
Figure S1: Exogenously expressed NAPs are polyglycylated by TTLL10
NAP1-EYFP and NAP2-EYFP were expressed alone or in combination with murine TTLL10-EYFP in U2OS 
cells. Upon overexpression of TTLL10-EYFP alone, the polyG antibody labels a strong protein band in the       
50 kDa region, which corresponds to endogenous NAPs (Fig. 2B, C). When NAP1-EYFP or NAP2-EYFP were 
co-expressed with TTLL10-EYFP, polyG recognizes additional protein bands at ~75 kDa, which are identified 
as NAP1 and NAP2 EYFP fusion proteins using anti-GFP labeling. Thus, NAP1 and NAP2 are polyglycylated 
by TTLL10 (Fig. 2B, C). 
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A Macaca mulatta TTLL10 mRNA ORF: 
ATGGCCCACAGCTGCACCCGGTTCGTCCATCGCCGGGGACCGCCCACTCGGACCCAAGCCGGCTCCAAGAGGGGCAAGAGACCAAAGATCCAGCGGCGGC
CTCGGGCTCGAGTCCCAGGCCCAGCCCATGAGAGGCCAATGGGGAGCAGCCAGGAGGAGGGACTCCCGTGTCAGCCAAGCCAGCCAGACCACGACACAGA
CTCGGATGACACTGATGCCACTGGGCCCCCAGCTGCCCTCCTGGAGGGGCTCCTGCTGGGGGACGGGAAGCCATCGCCCCACAGCACGAGGCCGGGACCT
TTCTTCTACATCGGAGGCAACAACGGGGCTGCGATCATCAGCTCCTACTGCAAAAGCAAGGGCTGGCGGCGCATCCAGGACAGCCGCCGGGAGGACTATG
TGCTGAAGTGGTGTGAGGTGAAGAGCCGAGACAGCTACGGCAGCTTCCGGGAAGGAGAGCAGCTGCTGTACCAGCTTCCCAACAACAAGCTCCTCACCAC
CAAGATCGGGCTGCTCAGCACCCTTCGGGGGCGGGCATGGGCCATGAGCAAGGCCAGCAAGGCGCCGGGGGGGACCCAGGCCAGGCTGGGAAAGGACGCA
ACAGCACCCACCCTGGAGGACCTCCCGTGGACAAGCCCAGGACACCTCAGGCCACAGAGGGTCCTGAGAATGGAGGAGTTTTTCCCAGAGACCTACCGCC
TGGACCTCAAGCACGAGAGAGAGGCTTTTTTCACCCTGTTTGACGAAACCCAGATATGGATCTGCAAGCCCACGGCCTCCAACCAGGGCAAAGGCATCTT
CCTGCTCCGGAAGCAGGAGGAAGTTGCCGCCCTGCAGGCCAAGACCCGGAGCGCGGAGGACGACCCCATCCACCATAAGTCGCCGTTCCGGGGGCCTCAG
GCGCGGGTGGTGCAGAGGTATATCCAGAACCCCCTGCTGCTGGATGGGAGGAAGTTTGACGTGCGCTCCTACCTGCTCATCGCCTGCACCACACCCTACA
TGATCTTCTTCAGCCACGGCTATGCCCGCCTCACCCTCAGCCTCTATGACCCCCATTCCAGCGACCTCAGCGGCCACCTGACCAACCAGTTCATGCAGAA
GAAGAGCCCGCTGTACGTGCTGCTGAAGGAGGACACGGTGTGGAGCATGGAGCGCCTCAACCGATACATCAACACCACGTTCTGGAAAGCCCGGGGCCTC
CCCAAGGACTGGGTCTTCACCACCCTCACGAAGCGGATGCAGCAGATCATGGCCCACTGCTTTCTGGCCGCCAAGTCCAAGCTGGAGTGCAAGCTGGGTT
ACTTTGACCTCATCGGCTGTGACTTCCTGATTGATGACAACTTCAAGGTATGGCTGCTGGAGATGAATTCCAACCCAGCCCTGCACACCAACTGCGAGGT
CCTGAAGGAGGTCATCCCAGGTGTGGTCATCGAGACCCTGGACCTGGCACTGGAGACCTTCCAGAAGAGCCTGCGCGGCCAGAAGATGCTGCCTCTGCTG
TCCCAGCGTCGCTTCGTGCTCCTGCACAACGGAGAGGCCGACGTGTGGCCGCGCCTGGGGGGCTCCTGCAGCCTCCACCGACGGCTGCCTCCGCCCACCC
GCCAGGCCAAGTCCTCCGGGCCACCCACGCCGCGTGCCCCAGACCAGCCGGGCACCCGCAGGCATGTGCCACCTCCCTTGGCACCGCAGCGTCCCCAGTT
GCCCGGCCCCAGTCCTGACCCAGATAGCGCCCACGATGGGCAGCCCCAGGCCCCGGGCAAGGAGCAGTCGGGCACAGGCGACAGGCACCCGGAGCAAGAG
CCTTCCCCGGGGACAGCCAAGGAGGAACGCAAGGAGCCCGAGAACGCGAGGCCCTGGGGCGGCCACCCACGCCCCACACCCCACGCCCCAGCCACACTGC
CCGCCTTCAGGGACCTATAA 
B Macaca mulatta TTLL10 protein sequence: 
MAHSCTRFVHRRGPPTRTQAGSKRGKRPKIQRRPRARVPGPAHERPMGSSQEEGLPCQPSQPDHDTDSDDTDATGPPAALLEGLLLGDG
KPSPHSTRPGPFFYIGGNNGAAIISSYCKSKGWRRIQDSRREDYVLKWCEVKSRDSYGSFREGEQLLYQLPNNKLLTTKIGLLSTLRGR
AWAMSKASKAPGGTQARLGKDATAPTLEDLPWTSPGHLRPQRVLRMEEFFPETYRLDLKHEREAFFTLFDETQIWICKPTASNQGKGIF
LLRKQEEVAALQAKTRSAEDDPIHHKSPFRGPQARVVQRYIQNPLLLDGRKFDVRSYLLIACTTPYMIFFSHGYARLTLSLYDPHSSDL
SGHLTNQFMQKKSPLYVLLKEDTVWSMERLNRYINTTFWKARGLPKDWVFTTLTKRMQQIMAHCFLAAKSKLECKLGYFDLIGCDFLID
DNFKVWLLEMNSNPALHTNCEVLKEVIPGVVIETLDLALETFQKSLRGQKMLPLLSQRRFVLLHNGEADVWPRLGGSCSLHRRLPPPTR
QAKSSGPPTPRAPDQPGTRRHVPPPLAPQRPQLPGPSPDPDSAHDGQPQAPGKEQSGTGDRHPEQEPSPGTAKEERKEPENARPWGGHP
RPTPHAPATLPAFRDL 
C Homo sapiens TTLL10 protein sequence: 
MDHSCTRFIHRRGPPTRTRAGFKRGKRPRIQQRPRARVSGtipasrlhpapasqpgpcpapghcpvgPAHERPMGSSQEEGLRCQPSQP
DHDADGHCGPDLEGAERASATPGPPGLLNSHRPADSDDTNAAGPSAALLEGLLLGGGKPSPHSTRPGPFFYIGGSNGATIISSYCKSKG
WQRIHDSRRDDYTLKWCEVKSRDSYGSFREGEQLLYQLPNNKLLTTKIGLLSTLRGRARAMSKASKVPGGVQARLEKDAAAPALEDLPW
TSPGYLRPQRVLRMEEFFPETYRLDLKHEREAFFTLFDETQIWICKPTASNQGKGIFLLRNQEEVAALQAKTRSMEDDPIHHKTPFRGP
QARVVQRYIQNPLLVDGRKFDVRSYLLIACTTPYMIFFGHGYARLTLSLYDPHSSDLGGHLTNQFMQKKSPLYMLLKEHTVWSMEHLNR
YISDTFWKARGLAKDWVFTTLKKRMQQIMAHCFLAAKPKLDCKLGYFDLIGCDFLIDDNFKVWLLEMNSNPALHTNCEVLKEVIPGVVI
ETLDLVLETFRKSLRGQKMLPLLSQRRFVLLHNGEADPRPHLGDSCSLRRWPPLPTRQAKSSGPPMPHAPDQPGARRPAPPPLVPQRPR
PPGPDLDSAHDGEPQAPGTEQSGTGNRHPAQEPSPGTAKEEREEPENARP 
 
 
Figure S2: Sequences of Macaca mulatta and Homo sapiens TTLL10. 
(A) Full coding sequence of Macaca mulatta TTLL10 according to our cloning and sequencing. PCR-related 
mutations have been eliminated. (B) Protein sequence of Macaca mulatta TTLL10. (C) Protein sequence of 
human TTLL10 (translation of AK124125). An alternatively spliced exon (corresponding amino acids 41-67, 
lower case letters) is absent in the TTLL10 we use in the present study. For simplification, the amino acid 
numbering according to the longest isoform of human TTLL10 is used throughout this study. 
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hsTTLL10     1 -MDHSCTRFIHRRGPPTRTRAGFK-RGKRP----------RIQ-------QRPR--------ARVSGT---IPASRLHPAPASQPGPCP- 
macTTLL10    1 -MAHSCTRFVHRRGPPTRTQAGSK-RGKRP----------KIQ-------RRPR--------ARVP------------------------ 
mmTTLL10     1 MALHPQAGRPHRDGSEAQAEAAAQDLGRLPSPSKVGAAVCRIQGLGHRAARRPRRGIGTTSASRVPRPGALMPATRNRPRFIHCRGQPPR 
 
 
hsTTLL10    60 -------------APGHCPV-GPAHERPMGSSQEEGLRCQPSQPDHDADGHCGPDLEGAERASATPGPPGLLNSHRPADSDDTNAAGPSA 
macTTLL10   40 ---------------------GPAHERPMGSSQEEGLPCQPSQPDHDTD------------------------------SDDTDATGPPA 
mmTTLL10    91 TRVSSKRSKRSRIHPCHTEVPGWTHEKQMGSSVKERLRPELSQLDQDAD-----------------------------DLEEEEAARLPV 
 
 
hsTTLL10   136 ALLEGLLLGGGKPSPHSTRPGPFFYIGGSNGATIISSYCKSKGWQRIHDSRRDDYTLKWCEVKSRDSYGSFREGEQLLYQLPNNKLLTTK 
macTTLL10   79 ALLEGLLLGDGKPSPHSTRPGPFFYIGGNNGAAIISSYCKSKGWRRIQDSRREDYVLKWCEVKSRDSYGSFREGEQLLYQLPNNKLLTTK 
mmTTLL10   152 TSPDGLLMEGDKQP--SPGQGPFFYIGGTNGASIISNYCESKGWQRTQDSHCEDYKLKWCEIKCRDNYCSFREGQQLLFQLPNNKLLTTK 
 
 
hsTTLL10   226 IGLLSTLRGRARAMSKASKVPGGVQARLEKDAAAPALEDLPWTSPGYLRPQRVLRMEEFFPETYRLDLKHEREAFFTLFDETQIWICKPT 
macTTLL10  169 IGLLSTLRGRAWAMSKASKAPGGTQARLGKDATAPTLEDLPWTSPGHLRPQRVLRMEEFFPETYRLDLKHEREAFFTLFDETQIWICKPT 
mmTTLL10   240 IGLLSALREHARTLSKARMLP-------------S-------T-QT-----KVLKMEEFFPETYRLDIRDERQAFFALFDETQMWICKPT 
 
 
mutation n° 
hsTTLL10   316 ASNQGKGIFLLRNQEEVAALQAKTRSMEDDPIHHKTPFRGPQARVVQRYIQNPLLVDGRKFDVRSYLLIACTTPYMIFFGHGYARLTLSL 
macTTLL10  259 ASNQGKGIFLLRKQEEVAALQAKTRSAEDDPIHHKSPFRGPQARVVQRYIQNPLLLDGRKFDVRSYLLIACTTPYMIFFSHGYARLTLSL 
mmTTLL10   304 ASNQGKGIFLIRSQEEAAALQAKTQSIEDDPIYRKMPFRAPQARVVQRYVQNPLLLDGKKFDVRSYMLIACAMPYMVFFGHGYARLTLSL 
 
 
mutation n° 
hsTTLL10   406 YDPHSSDLGGHLTNQFMQKKSPLYMLLKEHTVWSMEHLNRYISDTFWKARGLAKDWVFTTLKKRMQQIMAHCFLAAKPKLDCKLGYFDLI 
macTTLL10  349 YDPHSSDLSGHLTNQFMQKKSPLYVLLKEDTVWSMERLNRYINTTFWKARGLPKDWVFTTLTKRMQQIMAHCFLAAKSKLECKLGYFDLI 
mmTTLL10   394 YNPHSSDLSGHLTNQFMQKKSPLYTLLKESTVWTMEHLNRYINDKFRKTKGLPRDWVFTTFTKRMQQIMSHCFLAVKSKLECKLGYFDLI 
 
 
 
hsTTLL10   496 GCDFLIDDNFKVWLLEMNSNPALHTNCEVLKEVIPGVVIETLDLVLETFRKSLRGQKMLPLLSQRRFVLLHNGEA-DPRPHLGDSCSLRR 
macTTLL10  439 GCDFLIDDNFKVWLLEMNSNPALHTNCEVLKEVIPGVVIETLDLALETFQKSLRGQKMLPLLSQRRFVLLHNGEA-DVWPRLGGSCSLHR 
mmTTLL10   484 GCDFLIDENFKVWLLEMNANPALHTNCEVLKAVIPGVVIETLDLALETCQKSLHSQKMLPLLSQRRFVLLYNGETTDLWPRLASSRPLNR 
 
 
hsTTLL10   585 WP-PLPTRQAKSSGPPMPHAPDQPGARRPAPPPLVPQRPRPPGP--DLDSAHDGEPQAPGTEQSGTGNRHPAQEP-------SPGTAKEE 
macTTLL10  528 RL-PPPTRQAKSSGPPTPRAPDQPGTRRHVPPPLAPQRPQLPGPSPDPDSAHDGQPQAPGKEQSGTGDRHPEQEP-------SPGTAKEE 
mmTTLL10   574 LPNPNPNPNPNANPHPHPHPNPHPHPNPHPNANPHPPRPTCEAASSALSSARAAISERPGARKSMPSRGAPVCTPRKSRLSDSSGSSIAE 
 
 
hsTTLL10   665 RE----------EPENAR-P--------------------- 
macTTLL10  610 RK----------EPENAR-PWGGHPRPTPHAPATLPAFRDL 
mmTTLL10   664 SEPSLCSGSLEGSRDTAREPSLGPPEEEREEEQRSTSHRGS 
 
 
Figure S3: Sequence alignment and features of TTLL10 proteins. 
The protein sequences of human (hs; longest transcript; Fig. S2C), rhesus (Macaca mulatta; mac) and mouse 
(mm) TTLL10 have been aligned with Clustal X. Amino acid homologies (black) and similarities (gray) are 
indicated. The central region of the proteins, corresponding to the core TTL-domain (orange box; van Dijk et 
al., 2007), is highly homologous, whereas the flanking N- and C-terminal regions are more divergent, 
notably between mouse and the two primates. For the generation of chimeras (Fig. S4A) the central domains 
of rhesus and human TTLL10 were exchanged using the Sbf I and Eco RI restriction sites. Within this 
region, only 7 specific amino acid alterations between rhesus and human TTLL10 that could be responsible 
for the loss of activity of the human enzyme are present (green). 4 additional alterations between the 
sequence of rhesus and human TTLL10 correspond to non-conserved amino acids as they were also different 
in the active mouse TTLL10. Thus, they were not investigated. The essential ATP-interacting residue E511 
(hsTTLL10; *) is indicated in red. 
Sbf I 
Eco RI 
2 3 4 5 6 7 
* 
1 
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Figure S4: Mapping of the mutations that lead to the loss of enzymatic activity of human TTLL10.
(A) Schematic representation of chimeras generated by domain exchange between rhesus (red) and human 
(blue) TTLL10. The sequence positions of the exchange point are shown in Fig. S3. (B) To test the enzymatic 
activity of the respective constructs, rhesus and the chimeric TTLL10 proteins were expressed in U2OS cells. 
Only rhesus TTLL10 and chimera N°1 increased the polyG signal on NAPs, indicative of enzymatic activity of 
the proteins. This revealed that the loss of activity of human TTLL10 is related to amino acid changes in the 
central domain (amino acid 334-513; see Fig. S3) that corresponds approximately to the core TTL domain. 
(C) To map which of the single amino acid changes lead to a loss of TTLL10 activity, the 7 conserved mutations 
found in human TTLL10 (mut1-7; see Fig. S3) were separately introduced into rhesus TTLL10. Note that only 
two mutations, mut3 and 5 led to a complete loss of activity of rhesus TTLL10, as indicated by the absence of a 
polyG signal on immunoblot (WT: wild type). 
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Figure S5: The polymorphism of the human TTLL10 gene has no 
impact on the enzymatic activity of TTLL10 protein
(A) Alignment of DNA sequences of human genomic DNA from two 
individuals with European and central African origins. The mutation 
A1343G (mut3; nucleic acid count of the TTLL10 open reading frame), 
which introduces a N448S amino acid change into TTLL10 in individu-
als of European origin is absent in the TTLL10 gene of an individual of 
central African origin. In contrast, the mutation C1400A (T467K) is 
present in both individuals. Statistic data on the distribution of this 
polymorphism in the human population can be found at:
http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1320571
(B) Immunoblot of mouse and human (European and central African) 
sperm protein with polyG (polyglycylation), TAP952 (monoglycy-
lation) and 12G10 (α-tubulin). Despite the polymorphism in mut3 (A), 
both human individuals have no polyglycylation (polyG), instead 
strong monoglycylation was detected on α- and β-tubulin (TAP952). 
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Figure S6: Tissue-specific expression of the Drosophila melanogaster TTLL3A and TTLL3B genes
RT-PCR analysis of dmTTLL3A and dmTTLL3B in wild type flies. In male flies, testes were dissected from 
remaining body tissue and analyzed separately. Similarly, the ovaries and the body were analyzed from female 
flies. dmTTLL3A is expressed at moderate levels in the bodies of both, male and female flies, but very low 
expression levels are detected in testes and ovaries. In contrast, dmTTLL3B is highly expressed in testes, but at 
very low levels in other tissues (body). No dmTTLL3B expression was detected in ovaries.
The results are in agreement with published microarray expression data:
dmTTLL3A: http://flyatlas.org/atlas.cgi?name=FBgn0031854
dmTTLL3B: http://flyatlas.org/atlas.cgi?name=FBgn0031853.
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Supplementary tables: 
Table S1: Summary of the proteins identified in the major polyG-reactive protein spots after two-
dimensional gel electrophoresis (proteins chosen for further analysis are in bold letters) 
spot 
N° 
protein name accession 
N° 
gene  molecular 
weight (Da) 
N° of 
pep-
tides 
RMS score sequence 
coverage 
aldehyde 
dehydrogenase 
gi|20129399 CG3752 56,983 25 5 1797 57% 
amino peptidase gi|21355725 CG6372 61,474 11 3 729 24% 
RPT1 gi|17137738 CG1341 48,525 7 4 398 18% 
ERp60 gi|45445579 CG8983 55,235 10 2 482 28% 
TCP1η gi|23170738 CG8351 54,835 3 4 176 7% 
NADH-ubiquinone 
reductase 
gi|17933656 CG6343 46,868 2 3 156 9% 
aldehyde 
dehydrogenase 
gi|24650465 CG31075 52,573 4 3 188 9% 
enolase gi|7946 CG17654 46,534 3 2 145 11% 
1 
EF-1α gi|7915 CG8280 50,250 2 4 99 4% 
HSP60C gi|21064097 CG7235 61,570 28 6 2024 59% 
TCP1β gi|18858175 CG7033 58,047 20 3 
 
1515 52% 
α1 tubulin gi|17865841 CG9476 49,890 10 3 687 26% 
FK506-binding protein gi|24583150 CG4535 48,765 7 4 306 17% 
homolog of lipase gi|24642748 CG18258 51,135 2 8 141 4% 
homolog of leucine 
amino-peptidase 3  
gi|24661038 CG32351 61,333 2 4 144 5% 
hu-li tai shao protein gi|157747 CG9325 127,873 2 6 114 3% 
2 
homolog of 
xylulokinase  
gi|21356607 CG3534 61,115 3 2 113 6% 
paramyosin gi|10959 CG5939 102,322 46 4 3291 61% 
HSP60C gi|21064097 CG7235 61,520 3 3 263 10% 
3 
HSC70Cb gi|21357475 CG6603 88,484 4 2 191 6% 
4 HSP60B gi|15010456 CG2830 68,620 35 3 2680 64% 
HSP60A gi|33636453 CG12101 60,778 43 6 1643 76% 
esterase 6 gi|1832142 CG6917 61,109 10 4 646 23% 
5 
CG4546p gi|24647265 CG4546 52,111 4 6 275 10% 
ATP synthase β gi|24638766 CG11154 54,091 26 6 877 76% 
β2 tubulin gi|158743 CG9359 49,826 6 6 361 52% 
β3 tubulin gi|158749 CG3401 50,882 4 5 234 36% 
β4 tubulin gi|21428640 CG4869 51,220 2 7 164 10% 
loopin-1 gi|20130057 CG4750 56,686 3 3 259 7% 
6 
upheld 
(troponinT) 
gi|38570263 CG7107 47,431 4 2 259 12% 
 
Table S2: Complete mass spectrometry data of selected proteins; see attached file 
Rogowski_suppl_tableS2.xls 
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Supplementary text: 
To identify new substrates of polyglycylation form Drosophila testes, we resolved testes protein extracts 
using two-dimensional gel electrophoresis. The gel was stained with Coomassie brilliant blue, and in parallel 
immunoblots with polyG were performed from similar gel. Comparing the immunoblots to the stained gel, 
we identified 6 prominent spots that were labeled with polyG, and submitted these spots to mass 
spectrometry for protein identification. From the proteins that were identified in each spot (Table S1), we 
selected in most cases proteins with a high score for further analysis. Different paralogs of HSP60 were 
identified in several spots. We focused on HSP60B, since it has been the only protein detected in spot n°4. 
From spot n°1, we decided to select only RPT1, based on the consideration that the function of this protein 
as a subunit of the 26S proteasome could be important for sperm maturation (Zhong and Belote, 2007). From 
spot n°2 we chose TCP1β. From spot n°3 we chose all proteins except for the HSP60 paralog, whereas we 
decided not to analyze any protein from spot n°5. Spot n°6 was rich in β-tubulins, suggesting that the 
detected polyG signal was generated by polyglycylated forms of tubulin. Nevertheless we decided to 
investigate the modification of upheld, a homolog of troponin T, because this protein has an extended 
glutamate-rich C-terminal tail that could serve as a potential site of modification.  
The proteins chosen for further analysis, RPT1, TCP1β, paramyosin, HSC70Cb, HSP60B and troponin T 
were cloned into mammalian expression vectors bearing a C-terminal (or, in the case of troponin T, a N-
terminal) EYFP-tag. Expression in HEK293 cells confirmed that proteins of the correct size were expressed 
as EYFP-fusion proteins.  
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Supplementary materials and methods: 
Sequencing of human genomic DNA 
Genomic DNA was purified from human blood or sperm using the REDExtract-N-AmpTM Tissue PCR kit 
(Sigma, USA). Each DNA was amplified with the primer pair    
hTTLL10_seq_F1263 (5’-CATGCAGAAGAAGAGCCCTCTGTAC-3’)  
hTTLL10_seq_introRa (5’-CTGCCAAGTGGAGGATCTGAAAGG-3’)  
in two independent polymerase chain reactions (PCRs). The resulting PCR products of approximately 500 bp 
were purified and sequenced with both primers. No PCR-related mutation was detected.  
Protein identification by mass spectrometry 
Protein preparation for in gel digestion. The gel pieces were cut out from a Coomassie brilliant blue stained 
gel and successively washed with 50 µl of 25 mM NH4HCO3 and 50 µl of acetonitrile (three times), and 
dehydrated with 100 µl of acetonitrile before reduction in the presence of 10 mM DTT in 25 mM NH4HCO3 
(1 h at 57°C) and alkylation in the presence of 55 mM iodoacetamide in 25 mM NH4HCO3. For tryptic 
digestion, the gel pieces were resuspended in 2 volumes of trypsin (12.5 ng/µl; V5111 Promega, USA) 
freshly diluted in 25 mM NH4HCO3 and incubated overnight at 37°C. The digested peptides were then 
extracted from the gel in a buffer containing 34.9% H2O, 65% acetonitrile, and 0.1% HCOOH, and directly 
analyzed by nanoLC-MS/MS. 
Chromatography conditions on NanoAcquity. The analysis was performed on a nanoACQUITY Ultra-
Performance-LC (UPLC, Waters, Milford, USA). The samples were trapped on a 20х0.18 mm, 5 µm 
Symmetry C18 precolumn (Waters, Milford, USA), and the peptides were separated on a ACQUITY UPLC® 
BEH130 C18 column (Waters, Milford, USA), 75 µm x 200 mm, 1.7 µm particle size. The solvent system 
consisted of 0.1% formic acid in water (solvent A) and 0.1% formic acid in acetonitrile (solvent B). Trapping 
was performed during 3 min at 5 µl/min with 99% of solvent A and 1% of solvent B. Elution was performed 
at a flow rate of 400 nl/min, using 1-40% gradient (solvent B) over 35 min at 45°C followed by 65% (solvent 
B) over 5 min. 
MS and MS/MS conditions on SYNAPT mass spectrometer. The MS and MS/MS analyzes were performed 
on the SYNAPT™ an hybrid quadrupole orthogonal acceleration time-of-flight tandem mass spectrometer 
(Waters, Milford, USA) equipped with a Z-spray ion source and a lock mass system. The system operates in 
positive mode and the capillary voltage was set at 3.5 KV and the cone voltage at 35 V. Mass calibration of 
the TOF was achieved using phosphoric acid (H3PO4) on the [50;2000] m/z range. Online correction of this 
calibration was performed with Glu-fibrino-peptide B as the lock-mass. The ion (M+2H)2+ at m/z 785.8426 
is used to calibrate MS data and the fragment ion (M+H)+ at m/z 684.3469 is used to calibrate MS/MS data 
during the analysis. 
Supplementary material for Rogowski et al. 2009 11 
 
For tandem MS experiments, the system was operated with automatic switching between MS and MS/MS 
modes (MS 0.5 s/scan on m/z range [250;1500] and MS/MS 0.7 s/scan on m/z range [50;2000]). The 3 most 
abundant peptides (intensity threshold 60 counts/s), preferably doubly and triply charged ions, were selected 
on each MS spectrum for further isolation and CID fragmentation with 2 energies set using collision energy 
profile. Fragmentation was performed using argon as the collision gas. The complete system was fully 
controlled by MassLynx 4.1 (SCN 566, Waters, Milford, USA). Raw data collected during nanoLC-MS/MS 
analyses were processed and converted with ProteinLynx Browser 2.3 (Waters, Milford, USA) into .pkl peak 
list format. Normal background substraction type was used for both MS and MS/MS with 5% threshold and 
polynomial correction of order 5, and deisotoping was performed. 
Data analysis and protein identification. Mass data collected during LC-MS/MS analyses were processed 
using the software tool ProteinLynx Global Server (version 2.3; Waters, Milford, USA) converted into pkl 
files. The MS/MS data were analyzed using the MASCOT 2.2.0. algorithm (Matrix Science, UK) to search 
against a Drosophila melanogaster data base extracted from NCBInr (15th December 2008) concatenated 
with reversed copies of all sequences (182,083 entries). Spectra were searched with a mass tolerance of 
30 ppm for MS and 0.05 Da for MS/MS data, allowing a maximum of one missed cleavage site by trypsin 
and with carbamidomethylation of cysteines and oxidation of methionines fixed as variable modifications. 
Protein identifications were validated when at least two peptides were identified with Mascot ion score 
greater than 35 for each MS/MS spectra.  
For the estimation of the false positive rate in protein identification, a target-decoy database search was 
performed (Elias & Gygi, 2007). The false positive rate was close to 0.5%. 
Criteria used for protein identifications followed the general guidelines for reporting proteomic experiments 
(MIAPE; http://www.psidev.info) 
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